Indical Bioscience acquires Check-Points

Indical Bioscience signed an agreement to acquire Check-Points, a Dutch molecular diagnostics company and Dulisco venture. Check-Points is specialised in Salmonella typing for the food and veterinary market as well as antimicrobial resistance detection for human applications and through this acquisition the worldwide footprint of its unique, innovative products will be extended.

We congratulate Indical Bioscience and Check-Points with this great achievement and thank both parties for the great collaboration!

Read the full press release here.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound